These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 25619758)
1. Development and validation of the functional assessment of cancer therapy-antiangiogenesis subscale. Kaiser K; Beaumont JL; Webster K; Yount SE; Wagner LI; Kuzel TM; Cella D Cancer Med; 2015 May; 4(5):690-8. PubMed ID: 25619758 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). Cella D; Yount S; Du H; Dhanda R; Gondek K; Langefeld K; George J; Bro WP; Kelly C; Bukowski R J Support Oncol; 2006 Apr; 4(4):191-9. PubMed ID: 16669463 [TBL] [Abstract][Full Text] [Related]
3. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. Heffernan N; Cella D; Webster K; Odom L; Martone M; Passik S; Bookbinder M; Fong Y; Jarnagin W; Blumgart L J Clin Oncol; 2002 May; 20(9):2229-39. PubMed ID: 11980994 [TBL] [Abstract][Full Text] [Related]
4. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Brady MJ; Cella DF; Mo F; Bonomi AE; Tulsky DS; Lloyd SR; Deasy S; Cobleigh M; Shiomoto G J Clin Oncol; 1997 Mar; 15(3):974-86. PubMed ID: 9060536 [TBL] [Abstract][Full Text] [Related]
5. Development and initial validation of the NCCN/FACT symptom index for advanced kidney cancer. Rothrock NE; Jensen SE; Beaumont JL; Abernethy AP; Jacobsen PB; Syrjala K; Cella D Value Health; 2013; 16(5):789-96. PubMed ID: 23947972 [TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress. Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392 [TBL] [Abstract][Full Text] [Related]
7. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Cella D Semin Hematol; 1997 Jul; 34(3 Suppl 2):13-9. PubMed ID: 9253779 [TBL] [Abstract][Full Text] [Related]
8. Exploration of baseline patient-reported side effect bother from cancer therapy. Roydhouse JK; King-Kallimanis BL; Roy P; Weinstock C; Krol D; Daniels SR; Suzman DL; Beaver JA; Kluetz PG Clin Trials; 2020 Jun; 17(3):332-337. PubMed ID: 32153216 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and patient-based hearing status in conductive hearing loss. Stewart MG Laryngoscope; 2001 Nov; 111(11 Pt 2 Suppl 98):1-21. PubMed ID: 11802001 [TBL] [Abstract][Full Text] [Related]
10. Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire. Cella D; Jensen SE; Webster K; Hongyan D; Lai JS; Rosen S; Tallman MS; Yount S Value Health; 2012 Dec; 15(8):1051-8. PubMed ID: 23244807 [TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Chinese patients receiving maintenance dialysis. Wang SY; Zang XY; Liu JD; Gao M; Cheng M; Zhao Y J Pain Symptom Manage; 2015 Jan; 49(1):135-43. PubMed ID: 24878068 [TBL] [Abstract][Full Text] [Related]
12. Reliability and convergent and discriminant validity of the Child Oral Health Impact Profile (COHIP Child's version). Broder HL; Wilson-Genderson M Community Dent Oral Epidemiol; 2007 Aug; 35 Suppl 1():20-31. PubMed ID: 17615047 [TBL] [Abstract][Full Text] [Related]
14. Psychometric assessment of the MSAS-SF and the FACIT-Fatigue Scale in Spanish-speaking patients with cancer in Uruguay. Dapueto JJ; Abreu Mdel C; Francolino C; Levin R J Pain Symptom Manage; 2014 May; 47(5):936-45. PubMed ID: 24291293 [TBL] [Abstract][Full Text] [Related]
15. [Investigation and analysis of child neglect in 1163 urban children aged 3 - 6 years]. Yang ZN; Pan JP; Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):501-7. PubMed ID: 14746675 [TBL] [Abstract][Full Text] [Related]
16. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL Health Qual Life Outcomes; 2007 Feb; 5():11. PubMed ID: 17316442 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a scale to measure disease-related symptoms of kidney cancer. Cella D; Yount S; Brucker PS; Du H; Bukowski R; Vogelzang N; Bro WP Value Health; 2007; 10(4):285-93. PubMed ID: 17645683 [TBL] [Abstract][Full Text] [Related]
18. Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer. Bukowski R; Cella D; Gondek K; Escudier B; Am J Clin Oncol; 2007 Jun; 30(3):220-7. PubMed ID: 17551296 [TBL] [Abstract][Full Text] [Related]
19. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Yellen SB; Cella DF; Webster K; Blendowski C; Kaplan E J Pain Symptom Manage; 1997 Feb; 13(2):63-74. PubMed ID: 9095563 [TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]